RUBIUS THERAPEUTICS, INC.: cashflow_financing
| Value | {"amount": 198453000, "concept": "us-gaap:NetCashProvidedByUsedInFinancingActivities", "currency": "USD"} |
|---|---|
| Period | 2021-01-01 – 2021-12-31 |
| Status | current |
| Entity | RUBIUS THERAPEUTICS, INC. |
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
Retrieved: 2026-08-19T17:29:57.340308+02:00
Raw response sha256:
Also addressable by official identifiers:
Cite as: FACTANKER, https://factanker.com/fact/e601d836-0a1a-4122-8f39-4eeb8ad255d5
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
0001558370-22-002057Retrieved: 2026-08-19T17:29:57.340308+02:00
Raw response sha256:
f7bde1a401b286c74a2fd824ee1df541…Also addressable by official identifiers:
https://factanker.com/fact/sec/cik-0001709401/cashflow-financing/2021-12-31 (CIK, metric, reporting date)Cite as: FACTANKER, https://factanker.com/fact/e601d836-0a1a-4122-8f39-4eeb8ad255d5
History
- no predecessors — first report